Navigation Links
Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Chief Medical Officer
Date:6/9/2009

product candidates in development, and Nektar's collaborations with third parties. These forward-looking statements involve risks and uncertainties, including but not limited to: (i) Nektar's proprietary product candidates and those of its partners are in the early phases of clinical development and the risk of failure is high and can occur at any stage prior to regulatory approval; (ii) Nektar or its partners may not be able to successfully obtain regulatory approval for product candidates in development; (iii) Nektar's commercialization partners may not be successful in their sales and marketing efforts even if current product candidates successfully receive future regulatory approval in one or more markets; (iv) Nektar's patent applications for its technology platforms and proprietary or partner product candidates may not issue, patents that have issued may not be enforceable; and or intellectual property licenses from third parties may be required in the future; and (v) other important risks and uncertainties set forth in Nektar's most recent Quarterly Report on Form 10-Q filed on May 8, 2009 and its Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 6, 2009. Actual results could differ materially from the forward-looking statements contained in this press release. Nektar undertakes no obligation to update forward-looking statements, whether as a result of new information, future events or otherwise.

For more information on Nektar Therapeutics, please visit www.nektar.com

Jennifer Ruddock, 650-631-4954


'/>"/>
SOURCE Nektar Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Nektar Therapeutics Reports First Quarter 2009 Financial Results
2. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at the 29th Annual Cowen and Company Healthcare Conference in Boston
3. Nektar Therapeutics Reports Fourth Quarter and Year-End 2008 Financial Results
4. Nektar to Announce Year-End 2008 Financial Results on Wednesday, February 25, 2009 After Close of U.S.-Based Financial Markets
5. Nektar Announces Retirement of Irwin Lerner from Board of Directors
6. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at the 27th Annual J.P. Morgan Healthcare Conference in San Francisco
7. Nektar Announces Closing of Sale of Specific Pulmonary Delivery Assets to Novartis for $115 Million
8. Nektar Therapeutics to Webcast R&D Day on November 12th
9. Nektar Sells Pulmonary Business to Novartis For $115 Million and Nektar Retains Key Pulmonary Programs Including Amikacin Inhale, Inhaled Vancomycin, and Ciprofloxacin Inhalation Powder
10. Nektar Therapeutics President and CEO Howard W. Robin to Present at Natixis Bleichroeder Second Annual Hidden Gems Conference in New York City
11. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at UBS 2008 Global Life Sciences Conference in New York City
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... REYKJAVIK, Iceland , June 3, 2015   ... genome to improve health worldwide, today announced that it ... to provide clinical interpretation of the whole genome sequences ... of the first phase of the 100,000 Genomes Project ... WuXi NextCODE will deploy its unique database ...
(Date:6/3/2015)... 2015 Marktech Optoelectronics is pleased to ... APD’s have an internal gain mechanism, fast time response, ... infrared region. These APD’s are recommended for applications that ... to overcome high pre-amp noise. In addition, Marktech APD's ... ideal for extreme low-level light detection and short pulse ...
(Date:6/3/2015)... (PRWEB) June 03, 2015 GEA's ... , which is a standalone, fully-equipped laboratory unit that ... for limited productions in pilot plants. The Panther™ NS3006L ... its compact design allows for easy installation with simple ... products. This homogenizer can be used in many different ...
(Date:6/3/2015)... June 03, 2015 From smart street ... important part in enabling success in dealing with important ... technology leaders helped bring focus to the role and ... Photonics21 annual meeting last week in Brussels. ... event, held 28 and 29 May at the Hotel ...
Breaking Biology Technology:WuXi NextCODE Wins Genomics England Clinical Interpretation Tender in both Rare Disease and Cancer 2Marktech Introduces New Line of APDs 2GEA Announces the Panther™ NS3006L, a Self-Contained, Fully-Equipped Laboratory Homogenizer Well Suited for Pilot Plants 2Photonics21 Annual Meeting Focuses on Solutions for ‘Societal Challenges’ 2Photonics21 Annual Meeting Focuses on Solutions for ‘Societal Challenges’ 3
... taskforce of forest industry,stakeholders from Eastern Canada ... bio-related opportunities within the forestry sector across ... is comprised of regional government,industry, federal and ... has come together to better understand what,opportunities ...
... the Ferring Research,Infertility and Gynaecology GrAnt (FRIGGA) are ... & Embryology Congress. The two,winners of this new ... and the Universitair Ziekenhuis (UZ) Brussel, Centre for,Reproductive ... for their outstanding,proposals for fundamental research to help ...
... 7 Neurobiological,Technologies, Inc. (NTI(R)) (Nasdaq: NTII ), ... officer (CEO), has announced his,intent to retire on December ... serve on the Board. Mr. Freiman is the former ... Mr. Freiman is retiring after 11 years of ...
Cached Biology Technology:Atlantica BioEnergy Task Force Unveiled 2Ferring Research Infertility and Gynaecology GrAnt (FRIGGA) 2008 Winners Announced 2Ferring Research Infertility and Gynaecology GrAnt (FRIGGA) 2008 Winners Announced 3Neurobiological Technologies' CEO to Retire on December 31, 2008 2
(Date:4/14/2015)... , April 14, 2015  HYPR Corp. ... Online (FIDO ® ) Alliance tm , an ... FIDO members commit to share technology and collaborate ... that are interoperable, more secure and private, and ... biometric identity verification that protects sensitive user information ...
(Date:4/13/2015)... , April 13, 2015 ... TechSci Research, "Global Biometrics Market Forecast & Opportunities, 2020", ... a CAGR of around 14% till 2020. The ... for large scale implementation and review of biometric ... launch of new products with greater efficiency, are ...
(Date:4/10/2015)... Research and Markets ( http://www.researchandmarkets.com/research/cjk4gb/security ... Competitive Profiles - NEC" report to their offering. ... will continue to supply a range of IT security ... company focus on the development of a Big Data ... in the Asia-Pacific region is ...
Breaking Biology News(10 mins):HYPR Corp. Joins the FIDO Alliance 2HYPR Corp. Joins the FIDO Alliance 3Global Biometrics Market to Cross US$ 21 Billion by 2020: TechSci Research 2NEC Security Competitive Profile 2015 2
... for alternative ,medicines, and luxury goods in Asian markets, ... being invested in enforcement, while events such as China,s ... problem. However, research in Conservation Letters ... the ,War on Drugs, as they lack a long-term ...
... of Visualized Experiments , published a modern approach to ... intriguing research questions facing scientists todaythe origin of life ... is comprised of a modern and simplified approach to ... Harold Urey in 1953. Their research evaluated the possibility ...
... air pollution blowing across the Pacific Ocean is often caused ... and Europe, according to findings by UC Irvine and other ... Academy of Sciences . The study is the first ... is from the production in China of cellphones, televisions and ...
Cached Biology News:A 21st century adaptation of the Miller-Urey origin of life experiments 2Made in China for us: Air pollution tied to exports 2
PGF1α-d4 contains 4 deuterium atoms at the 3, 3', 4, and 4' positions. It is intended for use as an internal standard for the quantification of PGF1α by GC- or LC-mass spectrometry....
...
Antibodies were affinity purified using epitopes specific to PPP1CC immobilized on solid support....
ANTI GELSOLIN...
Biology Products: